Ultragenyx Pharmaceutical Current Ratio 2011-2026 | RARE

Annual Current Ratio Ultragenyx Pharmaceutical

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
0.955	1.21	1.23	1.3	2.54	2.91	2.36	6.5	4.57	6.67	16.1	15.5	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
16.1	0.955	5.15

Quarterly Current Ratio Ultragenyx Pharmaceutical

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
1.01	1.14	1.13	1.21	1.3	1.36	1.12	1.23	1.03	1.11	1.19	1.3	1.41	2.06	2.36	2.54	2.69	2.8	2.94	2.91	2.11	2.12	1.98	2.36	2.36	2.36	2.36	6.5	6.5	6.5	6.5	4.57	4.57	4.57	4.57	8.11	8.11	8.11	8.11	19.6	19.6	19.6	19.6	15.2	15.2	15.2	15.2	6.25	6.25	6.25	6.25	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
19.6	1.01	5.7

Current Ratio of other stocks in the Biotechnology industry

Issuer	Current Ratio	Price	% 24h	Market Cap	Country
Amgen AMGN	1.44	$ 350.13	2.98 %	$ 188 B	USA
MorphoSys AG MOR	1.02	-	2.43 %	$ 254 M	Germany
Acorda Therapeutics ACOR	1.61	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	1.65	-	-	$ 86.2 M	USA
Amneal Pharmaceuticals AMRX	2.2	$ 12.73	3.33 %	$ 3.99 B	USA
AlloVir ALVR	2.84	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	2.31	-	-	$ 10.1 M	USA
argenx SE ARGX	6.39	$ 783.17	2.32 %	$ 25 B	Niderland
Autolus Therapeutics plc AUTL	1.43	$ 1.48	8.82 %	$ 394 M	Britain
Applied Therapeutics APLT	0.762	-	-	$ 8.42 M	USA
I-Mab IMAB	8.96	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	3.59	-	-	$ 40.3 B	USA
Genfit SA GNFT	0.922	-	2.54 %	$ 160 B	France
Arcutis Biotherapeutics ARQT	1.78	$ 24.57	5.59 %	$ 3.13 B	USA
Biophytis SA BPTS	1.34	-	-13.47 %	$ 169 M	France
AVROBIO AVRO	15.9	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	6.43	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	1.75	-	-	$ 96.9 B	Britain
Midatech Pharma plc MTP	2.29	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	1.02	-	-1.52 %	$ 24.7 M	USA
BioNTech SE BNTX	7.95	$ 91.64	2.25 %	$ 27.2 B	Germany
BeiGene, Ltd. BGNE	2.14	-	0.49 %	$ 251 B	Cayman-islands
Alterity Therapeutics Limited ATHE	7.02	$ 3.82	1.6 %	$ 9.19 B	Australia
Burford Capital Limited BUR	2.14	$ 4.62	1.54 %	$ 742 M	Britain
CymaBay Therapeutics CBAY	3.05	-	-	$ 3.45 B	USA
Advaxis ADXS	5.93	-	-9.65 %	$ 45.9 M	USA
Aytu BioScience AYTU	1.47	$ 2.68	4.28 %	$ 16.8 M	USA
Avid Bioservices CDMO	1.22	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	4.17	-	-	$ 1.41 B	USA
Can-Fite BioPharma Ltd. CANF	2.76	$ 3.05	0.66 %	$ 6.64 B	Israel
Институт стволовых клеток человека ISKJ	1.04	-	-	-	Russia
Cabaletta Bio CABA	3.11	$ 3.05	-0.5 %	$ 306 M	USA
Checkpoint Therapeutics CKPT	0.372	-	-	$ 169 M	USA
Aeterna Zentaris AEZS	1.6	-	5.93 %	$ 314 M	Canada
Checkmate Pharmaceuticals CMPI	8.41	-	-	$ 231 M	USA
Cerus Corporation CERS	1.41	$ 1.93	4.62 %	$ 368 M	USA
AgeX Therapeutics AGE	0.995	-	-10.17 %	$ 12.2 K	USA
Concert Pharmaceuticals CNCE	3.11	-	-	$ 401 M	USA
Aeglea BioTherapeutics AGLE	12.4	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.79	-	-	$ 26.5 M	USA
CTI BioPharma Corp. CTIC	0.878	-	-	$ 1.2 B	USA
AIkido Pharma AIKI	2.59	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	0.269	-	-45.71 %	$ 1.2 M	Canada
Cyclacel Pharmaceuticals CYCCP	6.09	-	-4.36 %	$ 27 M	USA
Cellectar Biosciences CLRB	2.96	$ 2.83	2.91 %	$ 7.38 M	USA
Deciphera Pharmaceuticals DCPH	3.86	-	-	$ 2.18 B	USA
Akero Therapeutics AKRO	10.9	-	-	$ 3.67 B	USA
Dynavax Technologies Corporation DVAX	2.53	-	-	$ 2.02 B	USA
CureVac N.V. CVAC	2.47	-	-	$ 867 M	Germany
Coherus BioSciences CHRS	1.31	$ 1.73	3.59 %	$ 203 M	USA